Blog
EQS-News: LAIQON AG appoints Axel Hörger to the Executive Board as Chief Strategy Officer
EQS-News: LAIQON AG appoints Axel Hörger to the Executive Board as Chief Strategy Officer
LIGHTON: OREUS DISTRIBUTES LIGHTON’S AI ON ITS SOVEREIGN PLATFORM: A SECURE, TURNKEY SOLUTION FOR FRENCH COMPANIES AND INSTITUTIONS.
LIGHTON: OREUS DISTRIBUTES LIGHTON’S AI ON ITS SOVEREIGN PLATFORM: A SECURE, TURNKEY SOLUTION FOR FRENCH COMPANIES AND INSTITUTIONS.
Transaction in Own Shares
Transaction in Own Shares
First lifting of IOC pipeline exports
First lifting of IOC pipeline exports
EQS-News: cyan AG and Orange Réunion Mayotte partner to launch new cybersecurity service in Réunion and Mayotte for B2B and B2C customers
EQS-News: cyan AG and Orange Réunion Mayotte partner to launch new cybersecurity service in Réunion and Mayotte for B2B and B2C customers
EQS-News: YOC AG REPORTS GROWING REVENUES AMID OPERATIONAL CHALLENGES IN THE FIRST THREE QUARTERS OF THE 2025 FISCAL YEAR
EQS-News: YOC AG REPORTS GROWING REVENUES AMID OPERATIONAL CHALLENGES IN THE FIRST THREE QUARTERS OF THE 2025 FISCAL YEAR
EQS-News: Significant earnings jump in the third quarter despite challenging economic conditions – adjusted EBITDA in the JDC Group rises by 50 percent
EQS-News: Significant earnings jump in the third quarter despite challenging economic conditions – adjusted EBITDA in the JDC Group rises by 50 percent
EQS-News: SUSS presents ambitious plans for further sales growth and sustainable margin improvement at Capital Markets Day
EQS-News: SUSS presents ambitious plans for further sales growth and sustainable margin improvement at Capital Markets Day
SIG Group AG appoints Mikko Keto as Chief Executive Officer
SIG Group AG appoints Mikko Keto as Chief Executive Officer
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
Siegfried announces Chief Financial Officer transition
Siegfried announces Chief Financial Officer transition
Cicor announces strong order intake from Aerospace & Defence customers and completes the acquisition of two Valtronic production sites
Cicor announces strong order intake from Aerospace & Defence customers and completes the acquisition of two Valtronic production sites
EQS-News: Formycon achieves key development milestone with FYB208: Biosimilar candidate for Dupixent® (dupilumab) adds another growth driver to the biosimilar portfolio
EQS-News: Formycon achieves key development milestone with FYB208: Biosimilar candidate for Dupixent® (dupilumab) adds another growth driver to the biosimilar portfolio
EQS-News: Exercise of Options Warrants
EQS-News: Exercise of Options Warrants
Holding(s) in Company
Holding(s) in Company
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
Funding Circle Holdings plc: POS-Transaction in Own Shares
Funding Circle Holdings plc: POS-Transaction in Own Shares
Custodian Property Income REIT plc: Share Buyback
Custodian Property Income REIT plc: Share Buyback
Turkiye Garanti Bankasi A.S.: Prospectus – Capital Markets Instrument Note
Turkiye Garanti Bankasi A.S.: Prospectus – Capital Markets Instrument Note
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Turkiye Garanti Bankasi A.S.: Prospectus - Summary
Turkiye Garanti Bankasi A.S.: Prospectus - Summary
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: JTC plc
Form 8.3 - The Vanguard Group, Inc.: JTC plc
Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc


